PKC Regulates the Production of Fibroblast Growth Factor 23 (FGF23)

Overview

Journal PLoS One

Specialties General Medicine
Science

Date 2019 Mar 29

PMID 30921339

Citations 12

Authors

Ludmilla Bar

Philipp Hase

Michael Foller

Affiliations

Soon will be listed here.

Abstract

Serine/threonine protein kinase C (PKC) is activated by diacylglycerol that is released from membrane lipids by phospholipase C in response to activation of G protein-coupled receptors or receptor tyrosine kinases. PKC isoforms are particularly relevant for proliferation and differentiation of cells including osteoblasts. Osteoblasts/osteocytes produce fibroblast growth factor 23 (FGF23), a hormone regulating renal phosphate and vitamin D handling. PKC activates NFκB, a transcription factor complex controlling FGF23 expression. Here, we analyzed the impact of PKC on FGF23 synthesis. Fgf23 expression was analyzed by qRT-PCR in UMR106 osteoblast-like cells and in IDG-SW3 osteocytes, and FGF23 protein was measured by ELISA. Phorbol ester 12-O-tetradecanoylphorbol-13-acetate (PMA), a PKC activator, up-regulated FGF23 production. In contrast, PKC inhibitors calphostin C, Gö6976, sotrastaurin and ruboxistaurin suppressed FGF23 formation. NFκB inhibitor withaferin A abolished the stimulatory effect of PMA on Fgf23. PKC is a powerful regulator of FGF23 synthesis, an effect which is at least partly mediated by NFκB.

Citing Articles

Role of signaling pathways in age-related orthopedic diseases: focus on the fibroblast growth factor family.

Li H, Zhang J, Yuan D, Xie W, Ladel C, Mobasheri A Mil Med Res. 2024; 11(1):40.

PMID: 38902808 PMC: 11191355. DOI: 10.1186/s40779-024-00544-5.

Gα11 deficiency increases fibroblast growth factor 23 levels in a mouse model of familial hypocalciuric hypercalcemia.

Ay B, Cyr S, Klovdahl K, Zhou W, Tognoni C, Iwasaki Y JCI Insight. 2024; 9(9.

PMID: 38530370 PMC: 11141917. DOI: 10.1172/jci.insight.178993.

Only bioactive forms of PTH (n-oxPTH and Met18(ox)-PTH) inhibit synthesis of sclerostin - evidence from in vitro and human studies.

Li M, Hasan A, Chu C, Hocher J, Liu Y, Zhang X Pflugers Arch. 2024; 476(6):889-899.

PMID: 38393416 PMC: 11139748. DOI: 10.1007/s00424-024-02928-x.

PKC regulates αKlotho gene expression in MDCK and NRK-52E cells.

Wolf L, Vogt J, Alber J, Franjic D, Feger M, Foller M Pflugers Arch. 2023; 476(1):75-86.

PMID: 37773536 PMC: 10758369. DOI: 10.1007/s00424-023-02863-3.

Sodium butyrate enhances titanium nail osseointegration in ovariectomized rats by inhibiting the PKCα/NOX4/ROS/NF-κB pathways.

Liu Z, Yao X, Jiang W, Zhou Z, Yang M J Orthop Surg Res. 2023; 18(1):556.

PMID: 37528483 PMC: 10394859. DOI: 10.1186/s13018-023-04013-y.

References

Pulskens W, Verkaik M, Sheedfar F, van Loon E, van de Sluis B, Vervloet M . Deregulated Renal Calcium and Phosphate Transport during Experimental Kidney Failure. PLoS One. 2015; 10(11):e0142510. PMC: 4643984. DOI: 10.1371/journal.pone.0142510. View

Farrow E, Yu X, Summers L, Davis S, Fleet J, Allen M . Iron deficiency drives an autosomal dominant hypophosphatemic rickets (ADHR) phenotype in fibroblast growth factor-23 (Fgf23) knock-in mice. Proc Natl Acad Sci U S A. 2011; 108(46):E1146-55. PMC: 3219119. DOI: 10.1073/pnas.1110905108. View

Durlacher-Betzer K, Hassan A, Levi R, Axelrod J, Silver J, Naveh-Many T . Interleukin-6 contributes to the increase in fibroblast growth factor 23 expression in acute and chronic kidney disease. Kidney Int. 2018; 94(2):315-325. DOI: 10.1016/j.kint.2018.02.026. View

Zhang Q, Doucet M, Tomlinson R, Han X, Quarles L, Collins M . The hypoxia-inducible factor-1α activates ectopic production of fibroblast growth factor 23 in tumor-induced osteomalacia. Bone Res. 2016; 4:16011. PMC: 4948305. DOI: 10.1038/boneres.2016.11. View

Mochly-Rosen D, Das K, Grimes K . Protein kinase C, an elusive therapeutic target?. Nat Rev Drug Discov. 2012; 11(12):937-57. PMC: 3760692. DOI: 10.1038/nrd3871. View

Agoro R, Montagna A, Goetz R, Aligbe O, Singh G, Coe L . Inhibition of fibroblast growth factor 23 (FGF23) signaling rescues renal anemia. FASEB J. 2018; 32(7):3752-3764. PMC: 5998980. DOI: 10.1096/fj.201700667R. View

Kim J, Bae S, Choi J, Kim H, Ryoo H . The protein kinase C pathway plays a central role in the fibroblast growth factor-stimulated expression and transactivation activity of Runx2. J Biol Chem. 2002; 278(1):319-26. DOI: 10.1074/jbc.M203750200. View

Shimada T, Kakitani M, Yamazaki Y, Hasegawa H, Takeuchi Y, Fujita T . Targeted ablation of Fgf23 demonstrates an essential physiological role of FGF23 in phosphate and vitamin D metabolism. J Clin Invest. 2004; 113(4):561-8. PMC: 338262. DOI: 10.1172/JCI19081. View

Spichtig D, Zhang H, Mohebbi N, Pavik I, Petzold K, Stange G . Renal expression of FGF23 and peripheral resistance to elevated FGF23 in rodent models of polycystic kidney disease. Kidney Int. 2014; 85(6):1340-50. DOI: 10.1038/ki.2013.526. View

10.

Egli-Spichtig D, Zhang M, Perwad F . Fibroblast Growth Factor 23 Expression Is Increased in Multiple Organs in Mice With Folic Acid-Induced Acute Kidney Injury. Front Physiol. 2018; 9:1494. PMC: 6206018. DOI: 10.3389/fphys.2018.01494. View

11.

Kuro-O M, Moe O . FGF23-αKlotho as a paradigm for a kidney-bone network. Bone. 2016; 100:4-18. DOI: 10.1016/j.bone.2016.11.013. View

12.

Itoh N, Ohta H . Pathophysiological roles of FGF signaling in the heart. Front Physiol. 2013; 4:247. PMC: 3764331. DOI: 10.3389/fphys.2013.00247. View

13.

Jimbo R, Kawakami-Mori F, Mu S, Hirohama D, Majtan B, Shimizu Y . Fibroblast growth factor 23 accelerates phosphate-induced vascular calcification in the absence of Klotho deficiency. Kidney Int. 2013; 85(5):1103-11. DOI: 10.1038/ki.2013.332. View

14.

Lavi-Moshayoff V, Wasserman G, Meir T, Silver J, Naveh-Many T . PTH increases FGF23 gene expression and mediates the high-FGF23 levels of experimental kidney failure: a bone parathyroid feedback loop. Am J Physiol Renal Physiol. 2010; 299(4):F882-9. DOI: 10.1152/ajprenal.00360.2010. View

15.

Bar L, Feger M, Fajol A, Klotz L, Zeng S, Lang F . Insulin suppresses the production of fibroblast growth factor 23 (FGF23). Proc Natl Acad Sci U S A. 2018; 115(22):5804-5809. PMC: 5984514. DOI: 10.1073/pnas.1800160115. View

16.

Ito N, Wijenayaka A, Prideaux M, Kogawa M, Ormsby R, Evdokiou A . Regulation of FGF23 expression in IDG-SW3 osteocytes and human bone by pro-inflammatory stimuli. Mol Cell Endocrinol. 2014; 399:208-18. DOI: 10.1016/j.mce.2014.10.007. View

17.

Flamme I, Ellinghaus P, Urrego D, Kruger T . FGF23 expression in rodents is directly induced via erythropoietin after inhibition of hypoxia inducible factor proline hydroxylase. PLoS One. 2017; 12(10):e0186979. PMC: 5658123. DOI: 10.1371/journal.pone.0186979. View

18.

Glosse P, Feger M, Mutig K, Chen H, Hirche F, Hasan A . AMP-activated kinase is a regulator of fibroblast growth factor 23 production. Kidney Int. 2018; 94(3):491-501. DOI: 10.1016/j.kint.2018.03.006. View

19.

Stubbs J, Liu S, Tang W, Zhou J, Wang Y, Yao X . Role of hyperphosphatemia and 1,25-dihydroxyvitamin D in vascular calcification and mortality in fibroblastic growth factor 23 null mice. J Am Soc Nephrol. 2007; 18(7):2116-24. DOI: 10.1681/ASN.2006121385. View

20.

Orfanidou T, Iliopoulos D, Malizos K, Tsezou A . Involvement of SOX-9 and FGF-23 in RUNX-2 regulation in osteoarthritic chondrocytes. J Cell Mol Med. 2010; 13(9B):3186-94. PMC: 4516476. DOI: 10.1111/j.1582-4934.2009.00678.x. View